| D-0509-2024 | Class II | Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC | May 20, 2024 |
| D-0025-2023 | Class III | Susvimo (ranibizumab injection), 100mg/mL, sold together as a) carton containing One Susvimo single- | October 18, 2022 |
| D-0650-2021 | Class II | Xolair (omalizumab) Injection, 150 mg/1 mL, 1 prefilled syringe, Rx Only, For Subcutaneous Use. Sing | June 9, 2021 |
| D-0357-2021 | Class III | Evrysdi (risdiplam) for oral solution, 60 mg/80mL (0.75mg/mL), 80 mL total volume after constitution | April 20, 2021 |
| D-0416-2018 | Class III | Klonopin (clonazepam) 0.5 mg Tablets,100-count bottle, Rx only. Made in Canada, Distributed by Genen | February 5, 2018 |
| D-1175-2017 | Class I | Activase (alteplase), 100 mg (58 million IU), Lyophilized vial, packaged with 1 single-dose 100ml vi | September 5, 2017 |
| D-0648-2017 | Class II | Cotellic (cobimetinib) Tablets, 20 mg, 63 count bottle, Rx Only, Made in Switzerland. Distributed by | March 13, 2017 |
| D-097-2013 | Class III | CellCept (mycophenolate mofetil) capsules, 250 mg, packaged in a) 12 x 120-count bottles per carton, | September 27, 2012 |
| D-088-2013 | Class II | Nutropin AQ NuSpin 10 (somatropin (rDNA origin) injection} 10 mg/ 2mL Genentech, South San Francisco | September 20, 2012 |
| D-087-2013 | Class II | Nutropin AQ NuSpin 20 (somatropin (rDNA origin) injection} 20 mg/ 2mL Genentech, South San Francisco | September 20, 2012 |
| D-135-2013 | Class I | Trastuzumab Kit containing 1 vial Trastuzumab (nominal content: 440 mg); 1 20 mL multiple dose vial | July 30, 2012 |